HAWKHILL THERAPEUTICS Ltd, 2026-06-23
An SEC Form D private-offering notice from Dundee, Scotland, a $192,569 filer-stated offering target in Biotech. Filed 2026-06-23. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotech spinout from Tay Therapeutics developing a first-in-class oral therapy for obesity designed to reduce fat while preserving muscle mass.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- TETmedical, Inc., 2026-06-24, $9.8M, Fair Haven, NJ
- Quanta Therapeutics, Inc., 2026-06-24, $89.1M, South San Francisco, CA
- Dravite Therapeutics, Inc., 2026-06-24, $15M, San Francisco, CA
- Spearhead Bio, Inc., 2026-06-23, $1.8M, Saint Louis, MO
- Petragen, Inc., 2026-06-23, $1M, Davie, FL
- Nanomind, Inc., 2026-06-22, $3M, Stamford, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.